GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the SARS-cov-2(2019-ncov) main protease in complex with compound 21

Analyse Crystal structure of the SARS-cov-2(2019-ncov) main protease in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7L13
Type
protein
Length
606 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
XF7
Pockets
6 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30126% helix, 30% strandP0DTD1
B3C-like proteinase (EC 3.4.22.69)protein30525% helix, 29% strandP0DTD1

Ligands and binding sites

  • XF7 · (5S)-5-(3-{3-chloro-5-[(2-chlorophenyl)methoxy]phenyl}-2-oxo[2h-[1,3'-bipyridine]]-5-yl)pyrimidine-2,4(3H, 5H)-dione · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110650.770.7994empty
24050.570.7457empty
32100.480.7528empty
41790.460.7528empty
51750.460.7527XF7

Interfaces

1 interface between chains.

  • A–B · 1452 Ų buried · 37 hydrogen bonds · protein-protein

Compared structures

  • 7L13 · Crystal structure of the SARS-cov-2(2019-ncov) main protease in complex with compound 21 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.